Sarobe, P <br/><br/>
Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions.  [electronic resource] 

 -  The Journal of clinical investigation  Sep 1998 
 - 1239-48 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0021-9738 
<br/><br/><label>Standard No.: </label>10.1172/JCI3714  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alanine--genetics<br/>Animals<br/>Antigenic Variation<br/>Cytotoxicity, Immunologic<br/>Epitopes<br/>HLA-A2 Antigen--immunology<br/>Hepatitis C Antigens--genetics<br/>Humans<br/>Mice<br/>Mice, Transgenic<br/>Oligopeptides--genetics<br/>Protein Binding<br/>T-Lymphocytes, Cytotoxic<br/>Vaccination<br/>Viral Core Proteins--genetics<br/>Viral Hepatitis Vaccines--immunology